Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
COLLINS, M. D., LAWSON, P. A., WILLEMS, A., CORDOBA, J. J., FERNANDEZ-GARAYZABAL, J., GARCIA, P., CAI, J., HIPPE, H., & FARROW, J. A. E. (1994) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-44-4-812 · Cited by 1,669
Cited by
Items 401–500 of 1,009
Iron loss triggers mitophagy through induction of mitochondrial ferritin
Hara, Y., Yanatori, I., Tanaka, A., Kishi, F., Lemasters, J. J., Nishina, S., Sasaki, K., & Hino, K. (2020) · EMBO reports · doi:10.15252/embr.202050202 · Cited by 113
Completion of the gut microbial epi-bile acid pathway
Doden, H. L., Wolf, P. G., Gaskins, H. R., Anantharaman, K., Alves, J. M. P., & Ridlon, J. M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907271 · Cited by 123
Liu, B., Zhou, Z., Jin, Y., Lu, J., Feng, D., Peng, R., Sun, H., Mu, X., Li, C., & Chen, Y. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003069 · Cited by 112
Su, L., Hong, Z., Zhou, T., Jian, Y., Xu, M., Zhang, X., Zhu, X., & Wang, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-05127-9 · Cited by 129
The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review
Liu, L., & Shah, K. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.0494 · Cited by 111
Gut microbiota-mediated immunomodulation in tumor
Liu, X., Chen, Y., Zhang, S., & Dong, L. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01983-x · Cited by 112
Lau, H. C.-H., Zhang, X., & Yu, J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01089-1 · Cited by 138
Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle
García-Castillo, V., Sanhueza, E., McNerney, E. M., Oñate, S. A., & García, A. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000371 · Cited by 125
Organ-Specific Cancer Metabolism and Its Potential for Therapy
Elia, I., Schmieder, R., Christen, S., & Fendt, S. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_10 · Cited by 129
Maguire, M., & Maguire, G. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0024 · Cited by 111
NOD‐like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD
Ohashi, K., Wang, Z., Yang, Y. M., Billet, S., Tu, W., Pimienta, M., Cassel, S. L., Pandol, S. J., Lu, S. C.-L., Sutterwala, F. S., et al. (2019) · Hepatology · doi:10.1002/hep.30693 · Cited by 115
The Role of Diet in Cancer Prevention and Chemotherapy Efficacy
Mittelman, S. D. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-013120-041149 · Cited by 118
Gut microbiota and immunity relevance in eubiosis and dysbiosis
Al-Rashidi, H. E. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.10.068 · Cited by 105
The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma
Yang, P., Markowitz, G. J., & Wang, X. (2014) · National Science Review · doi:10.1093/nsr/nwu038 · Cited by 119
Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega
Doden, H. L., & Ridlon, J. M. (2021) · Microorganisms · doi:10.3390/microorganisms9030469 · Cited by 118
Nagathihalli, N. S., Beesetty, Y., Lee, W., Washington, M. K., Chen, X., Lockhart, A. C., & Merchant, N. B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2329 · Cited by 112
Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut
Ridlon, J. M., Kang, D.-J., Hylemon, P. B., & Bajaj, J. S. (2015) · Digestive Diseases · doi:10.1159/000371678 · Cited by 109
Healthy hosts rule within: ecological forces shaping the gut microbiota
Byndloss, M. X., Pernitzsch, S. R., & Bäumler, A. J. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0010-y · Cited by 109
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases
Yang, X., Lu, D., Zhuo, J., Lin, Z., Yang, M., & Xu, X. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46405 · Cited by 119
Kotsiliti, E., Leone, V., Schuehle, S., Govaere, O., Li, H., Wolf, M. J., Horvatic, H., Bierwirth, S., Hundertmark, J., Inverso, D., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.037 · Cited by 108
Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
Schneider, K. M., Elfers, C., Ghallab, A., Schneider, C. V., Galvez, E. J. C., Mohs, A., Gui, W., Candels, L. S., Wirtz, T. H., Zuehlke, S., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.11.002 · Cited by 108
Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma
Li, Z., Liu, H., He, J., Wang, Z., Yin, Z., You, G., Wang, Z., Davis, R. E., Lin, P., Bergsagel, P. L., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.011 · Cited by 107
Zong, X., Zhang, H., Zhu, L., Deehan, E. C., Fu, J., Wang, Y., & Jin, M. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.08.003 · Cited by 114
Brown, J. M., & Hazen, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.765388 · Cited by 108
Qin, X., Suzuki, H., Honda, M., Okada, H., Kaneko, S., Inoue, I., Ebisui, E., Hashimoto, K., Carninci, P., Kanki, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802279115 · Cited by 115
Gut Microbiota Interaction with the Central Nervous System throughout Life
Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 103
Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease
Tian, Y., Wong, V. W., Chan, H. L., & Cheng, A. S. L. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.010 · Cited by 111
FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis
Ji, S., Liu, Q., Zhang, S., Chen, Q., Wang, C., Zhang, W., Xiao, C., Li, Y., Nian, C., Li, J., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.12.021 · Cited by 106
Du, Y., Yang, W., Yang, C., & Yang, X. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.12.024 · Cited by 110
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
D’Ambrosio, M., & Gil, J. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.05.010 · Cited by 119
McClelland, J., Dalton, B., Kekic, M., Bartholdy, S., Campbell, I. C., & Schmidt, U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.024 · Cited by 104
Impact of granule size on microstructural changes and oil absorption of potato starch during frying
Chen, L., Ma, R., McClements, D. J., Zhang, Z., Jin, Z., & Tian, Y. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.03.046 · Cited by 105
Seyedsadjadi, N., & Grant, R. (2020) · Antioxidants · doi:10.3390/antiox10010015 · Cited by 102
Sethi, V., Vitiello, G. A., Saxena, D., Miller, G., & Dudeja, V. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.045 · Cited by 104
Significance of the gut microbiome in multistep colorectal carcinogenesis
Mizutani, S., Yamada, T., & Yachida, S. (2020) · Cancer Science · doi:10.1111/cas.14298 · Cited by 116
The gut microbiome-bile acid axis in hepatocarcinogenesis
Wu, L., Feng, J., Li, J., Yu, Q., Ji, J., Wu, J., Dai, W., & Guo, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111036 · Cited by 115
Host-microbe interactions in the gut of Drosophila melanogaster
Kuraishi, T., Hori, A., & Kurata, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00375 · Cited by 126
Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis
Du, K., Maeso-Díaz, R., Oh, S. H., Wang, E., Chen, T., Pan, C., Xiang, K., Dutta, R. K., Wang, X.-F., Chi, J.-T., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000326 · Cited by 102
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects
Legry, V., Francque, S., Haas, J. T., Verrijken, A., Caron, S., Chávez-Talavera, O., Vallez, E., Vonghia, L., Dirinck, E., Verhaegen, A., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01397 · Cited by 101
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
Kutlu, Ö., Kaleli, H. N., & Ozer, E. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/8543763 · Cited by 117
Murray, M. H., Lankau, E. W., Kidd, A. D., Welch, C. N., Ellison, T. J., Adams, H. C., Lipp, E. K., & Hernandez, S. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0220926 · Cited by 118
Physiological Role of Bile Acids Modified by the Gut Microbiome
Kiriyama, Y., & Nochi, H. (2021) · Microorganisms · doi:10.3390/microorganisms10010068 · Cited by 112
Assouline, B., Kahn, R., Hodali, L., Condiotti, R., Engel, Y., Elyada, E., Mordechay‐Heyn, T., Pitarresi, J. R., Atias, D., Steinberg, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50441-7 · Cited by 110
Toshima, T., Shirabe, K., Fukuhara, T., Ikegami, T., Yoshizumi, T., Soejima, Y., Ikeda, T., Okano, S., & Maehara, Y. (2014) · Hepatology · doi:10.1002/hep.27140 · Cited by 100
Hepatic senescence, the good and the bad
Huda, N., Liu, G., Hong, H., Yan, S., Khambu, B., & Yin, X.-M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5069 · Cited by 100
Schnupf, P., Gaboriau‐Routhiau, V., & Cerf–Bensussan, N. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.09.001 · Cited by 111
Nakamura, A., Ooga, T., & Matsumoto, M. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1494466 · Cited by 101
Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
Lapidot, Y., Amir, A., Nosenko, R., Uzan-Yulzari, A., Veitsman, E., Cohen‐Ezra, O., Davidov, Y., Weiss, P., Bradichevski, T., Segev, S., et al. (2020) · mSystems · doi:10.1128/msystems.00153-20 · Cited by 106
Emerging targetome and signalome landscape of gut microbial metabolites
Zheng, X., Cai, X., & Hao, H. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.011 · Cited by 101
Versatile Triad Alliance: Bile Acid, Taurine and Microbiota
Duszka, K. (2022) · Cells · doi:10.3390/cells11152337 · Cited by 110
The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
Huang, J.-H., Wang, J., Chai, X., Li, Z.-C., Jiang, Y.-H., Li, J., Liu, X., Fan, J., Cai, J., & Liu, F. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00983-22 · Cited by 118
Lade, A., Noon, L. A., & Friedman, S. L. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000042 · Cited by 100
Yan, F., Shen, N., Pang, J. X., Zhang, Y. W., Rao, E. Y., Bode, A. M., Al-Kali, A., Zhang, D. E., Litzow, M. R., Li, B., et al. (2017) · Leukemia · doi:10.1038/leu.2016.349 · Cited by 102
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Baboota, R. K., Rawshani, A., Bonnet, L., Li, X., Yang, H., Mardinoglu, A., Tchkonia, T., Kirkland, J. L., Hoffmann, A., Dietrich, A., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00620-x · Cited by 99
Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
Jiang, J., Chen, X., Ren, Z., & Zheng, S. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.11.002 · Cited by 107
Current and emerging strategies for the prevention of hepatocellular carcinoma
Yeo, Y. H., Abdelmalek, M. F., Khan, S. A., Moylan, C. A., Rodriquez, L. M., Villanueva, A., & Yang, J. D. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01021-z · Cited by 112
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Cogdill, A. P., Gaudreau, P. O., Arora, R., Gopalakrishnan, V., & Wargo, J. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.09.007 · Cited by 98
Matsudaira, T., Nakano, S., Konishi, Y., Kawamoto, S., Uemura, K., Kondo, T., Sakurai, K., Ozawa, T., Hikida, T., Komine, O., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05027-2 · Cited by 98
Self-citationEmerging role of aging in the progression of NAFLD to HCC
He, Y., Su, Y., Duan, C., Wang, S., He, W., Zhang, Y., An, X., & He, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101833 · Cited by 97
Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Higashimura, Y., Naito, Y., Takagi, T., Uchiyama, K., Mizushima, K., Ushiroda, C., Ohnogi, H., Kudo, Y., Yasui, M., Inui, S., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00324.2015 · Cited by 99
Panebianco, C., Oben, J. A., Vinciguerra, M., & Pazienza, V. (2016) · Clinical and Experimental Medicine · doi:10.1007/s10238-016-0438-x · Cited by 112
IL-1 Signaling in Tumor Microenvironment
Zhang, W., Borcherding, N. C., & Kolb, R. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38315-2_1 · Cited by 107
Microbiota-driven mechanisms at different stages of cancer development
Ivleva, E., & Grivennikov, S. I. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100829 · Cited by 103
Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration
Irvine, K. M., Skoien, R., Bokil, N. J., Melino, M., Thomas, G. P., Loo, D., Gabrielli, B., Hill, M. M., Sweet, M. J., Clouston, A. D., et al. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17851 · Cited by 97
Antrodia cinnamomea reduces obesity and modulates the gut microbiota in high-fat diet-fed mice
Chang, C.-J., Lu, C.-C., Lin, C.-S., Martel, J., Ko, Y.-F., Ojcius, D. M., Wu, T.-R., Tsai, Y.-H., Yeh, T.-S., Lu, J.-J., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.149 · Cited by 102
Sugiyama, Y., Mori, Y., Nara, M., Kotani, Y., Nagai, E., Kawada, H., Kitamura, M., Hirano, R., Shimokawa, H., Nakagawa, A., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2128605 · Cited by 108
Prinz, P., Hofmann, T., Ahnis, A., Elbelt, U., Goebel-Stengel, M., Klapp, B. F., Rose, M., & Stengel, A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00199 · Cited by 96
The microbiome and lung cancer
Maddi, A., Sabharwal, A., Violante, T., Manuballa, S., Genco, R. J., Patnaik, S. K., & Yendamuri, S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.88 · Cited by 101
Qiu, M., Huang, K., Liu, Y., Yang, Y., Tang, H., Liu, X., Wang, C., Chen, H., Xiong, Y., Zhang, J., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0144-6 · Cited by 102
Role of the microbiome in occurrence, development and treatment of pancreatic cancer
Wang, Y., Yang, G., You, L., Yang, J., Feng, M., Qiu, J., Zhao, F., Liu, Y., Cao, Z., Zheng, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1103-2 · Cited by 102
Microbiome and intestinal ischemia/reperfusion injury
Nadatani, Y., Watanabe, T., Shimada, S., Otani, K., Tanigawa, T., & Fujiwara, Y. (2018) · Journal of clinical biochemistry and nutrition · doi:10.3164/jcbn.17-137 · Cited by 81
Morgillo, F., Dallio, M., Corte, C. M. D., Gravina, A. G., Viscardi, G., Loguercio, C., Ciardiello, F., & Federico, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.002 · Cited by 106
Gut microbiota and health: connecting actors across the metabolic system
Fava, F., Rizzetto, L., & Tuohy, K. M. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002719 · Cited by 106
Microbial metabolites in non-alcoholic fatty liver disease
Zhou, D., & Fan, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i17.2019 · Cited by 106
Rajapakse, J., Khatiwada, S., Akon, A. C., Yu, K. L., Shen, S., & Zekry, A. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2240031 · Cited by 102
Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100018 · Cited by 112
Gut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 99
Gerritsen, J., Hornung, B., Ritari, J., Paulin, L. G., Rijkers, G. T., Schaap, P. J., de Vos, W. M., & Smidt, H. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/845511 · Cited by 136
Necrosis-Driven Systemic Immune Response Alters SAM Metabolism through the FOXO-GNMT Axis
Obata, F., Kuranaga, E., Tomioka, K., Ming, M., Takeishi, A., Chen, C., Soga, T., & Miura, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.046 · Cited by 100
Proteomics, Personalized Medicine and Cancer
Su, M., Zhang, Z., Zhou, L., Han, C., Huang, C., & Nice, E. C. (2021) · Cancers · doi:10.3390/cancers13112512 · Cited by 104
Bacterial induction of B cell senescence promotes age-related changes in the gut microbiota
Kawamoto, S., Uemura, K., Hori, N., Takayasu, L., Konishi, Y., Katoh, K., Matsumoto, T., Suzuki, M., Sakai, Y., Matsudaira, T., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01145-5 · Cited by 91
Self-citationKang, D., Su, M., Duan, Y., & Huang, Y. P. (2019) · Food & Function · doi:10.1039/c9fo00604d · Cited by 97
Nonalcoholic Fatty Liver Disease and the Gut Microbiome
Boursier, J., & Diehl, A. M. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.012 · Cited by 102
Interaction between periodontitis and liver diseases
Han, P., Sun, D., & Yang, J. (2016) · Biomedical Reports · doi:10.3892/br.2016.718 · Cited by 109
Cancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 90
Yitbarek, A., Taha-Abdelaziz, K., Hodgins, D. C., Read, L. R., Nagy, É., Weese, J. S., Caswell, J., Parkinson, J., & Sharif, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-31613-0 · Cited by 101
Microbiota and gastrointestinal cancer
Weng, M., Chiu, Y., Wei, P., Chiang, C.-W., Fang, H., & Wei, S. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.01.002 · Cited by 94
Sommer, F., & Bäckhed, F. (2016) · BioEssays · doi:10.1002/bies.201500151 · Cited by 91
Probiotics-mediated suppression of cancer
So, S. S. Y., Wan, M. L. Y., & El-Nezami, H. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000342 · Cited by 88
Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
Tu, T., Budzinska, M. A., Maczurek, A. E., Cheng, R., Bartolomeo, A. D., Warner, F. J., McCaughan, G. W., McLennan, S. V., & Shackel, N. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069422 · Cited by 94
Lee, D., Beack, S., Yoo, J., Kim, S., Lee, C., Kwon, W., Hahn, S. K., & Kim, C. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800941 · Cited by 89
Hong, Y., Li, B., Zheng, N., Wu, G., Ma, J., Tao, X., Chen, L., Zhong, J., Sheng, L., & Li, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00833 · Cited by 94
Yashaswini, C. N., Qin, T., Bhattacharya, D., Amor, C., Lowe, S., Lujambio, A., Wang, S., & Friedman, S. L. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.014 · Cited by 83
The Commensal Microbe V eillonella as a Marker for Response to an FGF19 Analog in NASH
Loomba, R., Ling, L., Dinh, D. M., DePaoli, A. M., Lieu, H. D., Harrison, S. A., & Sanyal, A. J. (2021) · Hepatology · doi:10.1002/hep.31523 · Cited by 88
“The hydrophobic, secondary bile acid deoxycholic acid (DCA) that was previously implicated in bile acid– associated carcinogenesis in animal models(25) was significantly and dose-dependently reduced with aldafermin treatment (decreases of 47%, 66%, 84%, and 92% in DCA were seen in patients receiving 0.”
BackgroundGoto, T., Itoh, M., Suganami, T., Kanai, S., Shirakawa, I., Sakai, T., Asakawa, M., Yoneyama, T., Kai, T., & Ogawa, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-26383-8 · Cited by 88
Lipometabolism and Glycometabolism in Liver Diseases
Ding, H., Wang, J., Ren, H., & Shi, X. (2018) · BioMed Research International · doi:10.1155/2018/1287127 · Cited by 96
How Comorbidities Shape Cancer Biology and Survival
Panigrahi, G., & Ambs, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.010 · Cited by 97
Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
Kreisinger, J., Schmiedová, L., Petrželková, A., Adámková, M., Tomášek, O., Martin, J., Michálková, R., & Albrecht, T. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00050 · Cited by 99
Metadata
- Authors
- Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., Honda, K., Ishikawa, Y., Hara, E., & Ohtani, N.
- Affiliations
- Japanese Foundation For Cancer Research (JP)
- Tokyo University of Science (JP)
- Japan Science and Technology Agency (JP)
- Tokushima University (JP)
- The University of Tokyo (JP)
- Azabu University (JP)
- Corresponding author
- Hara, Eiji
- ORCID
- Venue
- Nature
- Published
- 2013-06-26
- Volume
- 499
- Issue
- 7456
- Pages
- 97-101
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2132406938
- Cited by
- 2,219
- References
- 40
- Citations by year
- 2026: 131 · 2025: 164 · 2024: 175 · 2023: 196 · 2022: 208 · 2021: 224 · 2020: 198 · 2019: 175 · 2018: 172 · 2017: 142 · 2016: 130 · 2015: 125 · 2014: 125 · 2013: 47
- FWCI
- 63.80
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-01-29)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science (23300343, 221S0001, 24650625, 23300352, 25293080)
- Japan Science and Technology Agency
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- obesity, hepatocellular carcinoma, senescence-associated secretory phenotype, deoxycholic acid, gut microbiota, hepatic stellate cells, high-fat diet, bile acid metabolism, DNA damage, carcinogenesis, antibiotic intervention, chemical carcinogens, inflammation, obesity-related cancer, therapeutic target, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Bile Acids and Salts, Cells, Cultured, Deoxycholic Acid, Dietary Fats, Disease Models, Animal, DNA Damage, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Phenotype, Risk Factors, Cytokines, Cellular Senescence, Gastrointestinal Tract, Mice, Interleukin-1beta, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.